IL269123A - Methods of treating cancer - Google Patents
Methods of treating cancerInfo
- Publication number
- IL269123A IL269123A IL26912319A IL26912319A IL269123A IL 269123 A IL269123 A IL 269123A IL 26912319 A IL26912319 A IL 26912319A IL 26912319 A IL26912319 A IL 26912319A IL 269123 A IL269123 A IL 269123A
- Authority
- IL
- Israel
- Prior art keywords
- methods
- treating cancer
- cancer
- treating
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762468259P | 2017-03-07 | 2017-03-07 | |
| PCT/US2017/052663 WO2018164715A1 (en) | 2017-03-07 | 2017-09-21 | Methods of treating cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL269123A true IL269123A (en) | 2019-11-28 |
Family
ID=63447943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL26912319A IL269123A (en) | 2017-03-07 | 2019-09-04 | Methods of treating cancer |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP3592357A4 (https=) |
| JP (1) | JP7042836B2 (https=) |
| KR (1) | KR20190122251A (https=) |
| CN (1) | CN110430882A (https=) |
| AU (1) | AU2017402623A1 (https=) |
| CA (1) | CA3055308A1 (https=) |
| IL (1) | IL269123A (https=) |
| TW (1) | TW201832768A (https=) |
| WO (1) | WO2018164715A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022011037A2 (en) * | 2020-07-07 | 2022-01-13 | The General Hospital Corporation | Interleukin 33 (il-33) inhibition for treatment of cancer, fibrosis and inflammation |
| WO2023043375A2 (en) * | 2021-09-16 | 2023-03-23 | Agency For Science, Technology And Research | Modulation of tjp1 expression to treat liver diseases |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050107475A1 (en) * | 2002-03-21 | 2005-05-19 | Jones Stacey A. | Methods of using farnesoid x receptor (frx) agonists |
| US7932244B2 (en) | 2006-06-27 | 2011-04-26 | Intercept Pharmaceuticals, Inc. | Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions |
| WO2013037482A1 (en) * | 2011-09-15 | 2013-03-21 | Phenex Pharmaceuticals Ag | Farnesoid x receptor agonists for cancer treatment and prevention |
| AU2013352288B2 (en) * | 2012-11-28 | 2017-11-23 | Intercept Pharmaceuticals, Inc. | Treatment of pulmonary disease |
| US10166246B2 (en) * | 2014-05-27 | 2019-01-01 | City Of Hope | TGR5 agonist complexes for treating diabetes and cancer |
| US11578097B2 (en) * | 2014-11-26 | 2023-02-14 | Enanta Pharmaceuticals, Inc. | Tetrazole derivatives of bile acids as FXR/TGR5 agonists and methods of use thereof |
| PE20180690A1 (es) * | 2015-04-27 | 2018-04-23 | Intercept Pharmaceuticals Inc | Composiciones de acido obeticolico y metodos de uso |
| WO2017180577A1 (en) | 2016-04-13 | 2017-10-19 | Intercept Pharmaceuticals, Inc. | Methods of treating cancer |
-
2017
- 2017-08-11 TW TW106127326A patent/TW201832768A/zh unknown
- 2017-09-21 CA CA3055308A patent/CA3055308A1/en not_active Abandoned
- 2017-09-21 EP EP17899634.4A patent/EP3592357A4/en not_active Withdrawn
- 2017-09-21 JP JP2019548368A patent/JP7042836B2/ja active Active
- 2017-09-21 CN CN201780088500.7A patent/CN110430882A/zh active Pending
- 2017-09-21 WO PCT/US2017/052663 patent/WO2018164715A1/en not_active Ceased
- 2017-09-21 KR KR1020197029033A patent/KR20190122251A/ko not_active Withdrawn
- 2017-09-21 AU AU2017402623A patent/AU2017402623A1/en not_active Abandoned
-
2019
- 2019-09-04 IL IL26912319A patent/IL269123A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2018164715A1 (en) | 2018-09-13 |
| KR20190122251A (ko) | 2019-10-29 |
| TW201832768A (zh) | 2018-09-16 |
| EP3592357A1 (en) | 2020-01-15 |
| CN110430882A (zh) | 2019-11-08 |
| JP2020510009A (ja) | 2020-04-02 |
| JP7042836B2 (ja) | 2022-03-28 |
| AU2017402623A1 (en) | 2019-09-26 |
| EP3592357A4 (en) | 2021-01-13 |
| CA3055308A1 (en) | 2018-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL275663A (en) | Cancer treatment methods | |
| ZA201804227B (en) | Methods of treating cancer | |
| IL255189A0 (en) | Cancer treatment methods | |
| IL263925A (en) | Methods of treating ovarian cancer | |
| IL262342A (en) | Cancer treatment methods | |
| IL277981A (en) | Cancer treatment methods | |
| ZA201808258B (en) | Methods of treating pancreatic cancer | |
| PT3490560T (pt) | Niraparib para utilização num método de tratamento de cancro da próstata | |
| ZA201908539B (en) | Method of treatment of cancer | |
| SG11202010793UA (en) | Methods of treating cancer | |
| IL263835A (en) | Exosome-guided treatment of cancer | |
| IL281600B2 (en) | Cancer treatment methods | |
| EP3487999A4 (en) | METHODS OF TREATING CANCER | |
| GB201717945D0 (en) | Method for treatment of cancer | |
| SG11202005163PA (en) | Methods of treating cancer | |
| IL269123A (en) | Methods of treating cancer | |
| IL274748A (en) | Improved cancer treatment | |
| EP3389670A4 (en) | METHODS OF TREATING BREAST CANCER | |
| SG11202000839TA (en) | Methods of treating cancer by inhibiting setd2 | |
| HK40032563A (en) | Methods of treating cancer | |
| GB201702139D0 (en) | Methods of cancer treatment | |
| HK40016485A (en) | Methods of treating cancer | |
| GB201704287D0 (en) | Treatment of cancer | |
| GB201703857D0 (en) | Treatment of cancer | |
| GB201702565D0 (en) | Treatment of cancer |